Tilray | TRLY - 营业利润



金融业
股票价格
USD
资产
USD 2.1B
现金及等价物
USD 264.83M
销售成本
USD 164.37M
流动资产
USD 729.32M
流动负债
USD 259.32M
债务
USD 640.95M
EBIT
USD -20.01M
EBITDA
USD 8.37M
员工
USD 2.84K
EPS每股收益
USD -0.41
股本和储备
USD 1.58B
销售毛利
USD 57.47M
债务利息支出
USD 6.7M
利息收入
USD 12.83M
贷款资金
USD 268.59M
市值
USD 4.44B
净收入
USD -44.93M
营业费用
USD 237.52M
营业利润
USD -20.01M
普通股股本
USD 116.52M
PE价格收益
11.57
税前利润
USD -39.96M
销售收入
USD 217.51M
销售和管理费用
USD 24.85M
股票
USD 282.79M
贸易债权人
USD 114.5M
应收帐款人
USD 109.07M


营业利润 更改 日
Acasti Pharma USD -2.53M 560K 2025-09
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.01M 175K 2026-03
Aurora Cannabis CAD -10.03M 25.76M 2026-03
Avita Medical AUD -10.41M 742K 2025-12
Canopy Growth CAD -27.47M 14.81M 2026-03
Cronos Group USD 7.6M 9.06M 2026-06
Dianthus Therapeutics USD -46.53M 23.01M 2026-03
Divis Laboratories Ltd INR 11.29B 3.15B 2026-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
IQVIA Holdings USD 2.6B 2.03B 2026-06
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Moderna USD -815M 573M 2026-06
Organigram Holdings CAD -9.79M 10.33M 2026-03
Organon & Co USD 323M 57M 2026-06
Revvity USD 126.14M 43.36M 2026-06
Tectonic Therapeutic USD -27.3M 5.78M 2026-03
Tilray USD -20.01M 9.34M 2025-09
Viatris USD 73.7M 93.9M 2026-06
Xeris Pharmaceuticals USD 7.92M 8.86M 2026-03
Zealand Pharma A/S -539M 168.05M 2026-03